柴芍舒筋汤加减治疗纤维肌痛综合征的临床经验
Clinical Experience of Chaishao Shujin Decoction in the Treatment of Fibromyalgia Syndrome
摘要: 纤维肌痛综合征是临床常见的一种疾病,以全身弥漫性非炎性肌肉骨骼疼痛为主要特征,伴有不同程度的疲劳、睡眠、情绪障碍以及认知、身体功能受损。中医认为纤维肌痛综合征主要病因分内因及外因,内因多为肝郁脾虚、阳气不足,郁阻气机、筋脉失养、阳气不足、失于温煦,不荣则痛;其外因多为风寒湿热邪气痹阻经脉,气血运行不畅,不通则痛。纤维肌痛综合征病机为枢机不利,气滞湿蕴,筋脉痹阻,肌肉失养,其治则主以祛除外邪,疏肝健脾、疏利气机,标本兼治。笔者临床以柴芍舒筋汤加减(柴胡,白芍,白术,茯苓,当归,川芎,黄芪,香附,木瓜,伸筋草,烫狗脊,地龙,茯神,夜交藤,炙甘草)治疗纤维肌痛综合征,颇有心得,为临床治疗纤维肌痛综合征提供参考。
Abstract: Fibromyalgia syndrome is a common clinical disease mainly characterized by diffuse non-in- flam-matory musculoskeletal pain, accompanied by varying degrees of fatigue, sleep, emotional disor-ders and cognitive and physical impairment. According to Chinese medicine, the main causes of fi-bromyalgia syndrome are internal and external causes. The internal causes are mainly liver de-pression and spleen deficiency, lack of Yang Qi, blockage of qi, loss of muscles and veins, lack of Yang Qi, loss of warmth, and pain. Its external causes are mostly wind-cold dampness-heat evil qi block-age meridians, Qi and blood running smoothly, and pain. The pathogenesis of fibromyalgia syn-drome is unfavorable, Qi stagnation and wet accumulation, muscle blockage and muscle loss, and its treatment is mainly to remove external evil, soothing the liver and strengthening the spleen, Shuli Qi, and treating both symptoms and root causes. The author used Chaishao Shujin Decoction (Bu-pleurum, Paeoniae, Baizhu, Tuckahoe, Dang GUI, Chuanxixiong, Astragalus, Xiangfu, papaya, Xinjin-cao, hot dog’s spine, Dilong, Fu Shen, night Jiaoteng, and licorice) to treat fibromyalgia syndrome, and had some experience in the treatment of fibromyalgia syndrome.
文章引用:钟敏. 柴芍舒筋汤加减治疗纤维肌痛综合征的临床经验[J]. 中医学, 2023, 12(10): 2976-2982. https://doi.org/10.12677/TCM.2023.1210448

参考文献

[1] Berwick, R., Barker, C., Goebel, A. and Guideline Development Group (2022) The Diagnosis of Fibromyalgia Syn-drome. Clinical Medicine, 22, 570-574.
[2] Giorgi, V., Sirotti, S., Romano, M.E., Marotto, D., Ablin, J.N., Salaffi, F. and Sarzi-Puttini, P. (2022) Fibromyalgia: One Year in Review 2022. Clinical and Experimental Rheumatology, 40, 1065-1072. [Google Scholar] [CrossRef] [PubMed]
[3] Sarzi-Puttini, P., Giorgi, V., Atzeni, F., et al. (2021) Fi-bromyalgia Position Paper. Clinical and Experimental Rheumatology, 39, 186-193. [Google Scholar] [CrossRef] [PubMed]
[4] 姜刚刚, 田杰祥, 漆文霞, 等. 维生素D在纤维肌痛综合征中的影响机制及研究进展[J]. 风湿病与关节炎, 2022, 11(9): 63-68.
[5] Makrani, A.H., Afshari, M., Ghajar, M., Forooghi, Z. and Moosazadeh, M. (2017) Vitamin D and Fibromyalgia: A Meta-Analysis. The Korean Journal of Pain, 30, 250-257. [Google Scholar] [CrossRef] [PubMed]
[6] Carvalho, J.F., Araújo, F., Mota, L., et al. (2018) Vitamin D Supplementation Seems to Improve Fibromyalgia Symptoms: Preliminary Results. The Israel Medical Asso-ciation Journal, 20, 379-381.
[7] Siracusa, R., Paola, R.D., Cuzzocrea, S. and Impellizzeri, D. (2021) Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. International Journal of Molecular Sciences, 22, Article 3891. [Google Scholar] [CrossRef] [PubMed]
[8] 敖家凤, 王建明. 从阳气失常论治纤维肌痛综合征[J]. 中日友好医院学报, 2023, 37(4): 238-240.
[9] 中华中医药学会风湿病分会, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会纤维肌痛综合征中西医研究学组, 首都中西医结合风湿免疫病研究所. 中国纤维肌痛综合征诊疗指南[J]. 中华内科杂志, 2023, 62(2): 129-146.
[10] 张明远, 许二平, 陈毅恒, 等. 柴胡治疗抑郁症药理作用的研究现状[J/OL]. 中华中医药学刊: 1-12, 2023-08-29. http://125.221.83.226:18/rwt/CNKI/http/NNYHGLU DN3WXTLUPMW4A/kcms/detail/21.1546.R.20230509. 1445.010.html
[11] 刘瑶, 李雨, 王豆, 等. 中药白芍治疗帕金森病药理机制研究进展[J]. 辽宁中医药大学学报, 2023, 25(7): 197-201. [Google Scholar] [CrossRef
[12] 柳威, 邓林华, 赵英强. 白术及其有效成分药理作用概述[J]. 中医药学报, 2021, 49(10): 116-118. [Google Scholar] [CrossRef
[13] 左军, 祁天立, 胡晓阳. 茯苓化学成分及现代药理研究进展[J]. 中医药学报, 2023, 51(1): 110-114. [Google Scholar] [CrossRef
[14] 吕成龙, 李会会, 史永洁, 等. 中药当归现代研究进展及其质量标志物的预测分析[J]. 中国中药杂志, 2022, 47(19): 5140-5157. [Google Scholar] [CrossRef] [PubMed]
[15] 邱建利, 张慧娟, 赵倩义, 等. 基于网络药理学的川芎作用机制研究[J]. 医药论坛杂志, 2021, 42(7): 1-6, 11.
[16] 唐亚芳, 杨岸新. 中药川芎的有效成分及其药理作用研究[J]. 中国现代药应用, 2018, 12(10): 219-220. [Google Scholar] [CrossRef
[17] 汪志萍. 中药黄芪的药理及临床应用价值研究[J]. 内蒙古中医药, 2022, 41(9): 129-131. [Google Scholar] [CrossRef
[18] 徐秀梅, 刘文建. 香附药理作用及临床应用的进展[J]. 广东化工, 2023, 50(9): 69, 122-123.
[19] 代琪, 佘颖祺, 叶俏波, 等. 中药木瓜和木瓜籽的化学成分及药理作用研究进展[J]. 亚太传统医药, 2021, 17(8): 219-223.
[20] 蒋涛, 孔博, 颜威, 等. 基于网络药理学研究络石藤-伸筋草药对治疗骨关节炎的作用机制[J]. 世界中医药, 2020, 15(24): 3733-3739.
[21] 朱杰, 于立芹, 张华南, 等. 伸筋草经皮给药对小鼠抗炎镇痛作用及机制研究[J]. 中医药导报, 2021, 27(6): 40-44. [Google Scholar] [CrossRef
[22] 王继坤, 宋长红, 关秀锋. 伸筋草的化学成分及药理作用研究进展[J]. 化学工程师, 2021, 35(7): 55-57. [Google Scholar] [CrossRef
[23] 时圣明, 袁永兵, 兰新新, 等. 狗脊的化学成分及药理作用研究进展[J]. 药物评价研究, 2016, 39(3): 489-492.
[24] 王艳丽, 宁宇, 丁莹. 地龙的化学成分及药理作用研究进展[J]. 中医药信息, 2022, 39(12): 86-89. [Google Scholar] [CrossRef
[25] 郭征兵. 中药地龙的药理作用及活性成分分析[J]. 当代医学, 2017, 23(19): 199-200.
[26] 戴慧, 覃欣怡, 端木彦涛, 等. 茯神的化学成分、药理作用及质量控制研究进展[J]. 江西中医药, 2022, 53(10): 68-72.
[27] 佟一鑫, 柏强. 基于网络药理学和分子对接技术探究夜交藤治疗失眠的作用机制[J]. 中医临床研究, 2021, 13(26): 1-5.
[28] 陶丽宇, 高月求, 韦靖, 等. 首乌藤相关药理作用及临床运用的研究进展[J]. 时珍国医国药, 2018, 29(10): 2486-2488.
[29] 王波, 王丽, 刘晓峰, 等. 中药甘草成分和药理作用及其现代临床应用的研究进展[J]. 中国医药, 2022, 17(2): 316-320.